Annual FCF:
-$110.34M-$12.65M(-12.95%)Summary
- As of today, EWTX annual free cash flow is -$110.34 million, with the most recent change of -$12.65 million (-12.95%) on December 31, 2024.
- During the last 3 years, EWTX annual free cash flow has fallen by -$76.17 million (-222.87%).
- EWTX annual free cash flow is now -1079.98% below its all-time high of -$9.35 million, reached on December 31, 2019.
Performance
EWTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$32.63M+$5.28M(+13.92%)Summary
- As of today, EWTX quarterly free cash flow is -$32.63 million, with the most recent change of +$5.28 million (+13.92%) on June 30, 2025.
- Over the past year, EWTX quarterly free cash flow has dropped by -$6.31 million (-23.98%).
- EWTX quarterly free cash flow is now -1087.48% below its all-time high of -$2.75 million, reached on March 31, 2020.
Performance
EWTX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$125.67M-$6.31M(-5.29%)Summary
- As of today, EWTX TTM free cash flow is -$125.67 million, with the most recent change of -$6.31 million (-5.29%) on June 30, 2025.
- Over the past year, EWTX TTM free cash flow has dropped by -$20.95 million (-20.00%).
- EWTX TTM free cash flow is now -4473.03% below its all-time high of -$2.75 million, reached on March 31, 2020.
Performance
EWTX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EWTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -12.9% | -24.0% | -20.0% |
| 3Y3 Years | -222.9% | -94.3% | -162.1% |
| 5Y5 Years | -1080.0% | -682.0% | -1715.7% |
EWTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -222.9% | at low | -145.5% | +13.9% | -139.2% | at low |
| 5Y | 5-Year | -1080.0% | at low | -682.0% | +13.9% | -1715.7% | at low |
| All-Time | All-Time | -1080.0% | at low | -1087.5% | +13.9% | -4473.0% | at low |
EWTX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$32.63M(+13.9%) | -$125.67M(-5.3%) |
| Mar 2025 | - | -$37.91M(-39.2%) | -$119.36M(-8.2%) |
| Dec 2024 | -$110.34M(-12.9%) | -$27.23M(+2.4%) | -$110.34M(-0.2%) |
| Sep 2024 | - | -$27.89M(-6.0%) | -$110.10M(-5.1%) |
| Jun 2024 | - | -$26.32M(+8.9%) | -$104.72M(-5.4%) |
| Mar 2024 | - | -$28.89M(-7.1%) | -$99.39M(-1.7%) |
| Dec 2023 | -$97.69M(-67.9%) | -$26.99M(-19.9%) | -$97.69M(-13.8%) |
| Sep 2023 | - | -$22.52M(-7.3%) | -$85.85M(-12.0%) |
| Jun 2023 | - | -$20.99M(+22.8%) | -$76.63M(-5.8%) |
| Mar 2023 | - | -$27.19M(-79.5%) | -$72.43M(-24.5%) |
| Dec 2022 | -$58.18M | -$15.15M(-14.0%) | -$58.18M(-10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$13.29M(+20.9%) | -$52.53M(-9.6%) |
| Jun 2022 | - | -$16.80M(-29.8%) | -$47.95M(-17.0%) |
| Mar 2022 | - | -$12.94M(-36.2%) | -$41.00M(-20.0%) |
| Dec 2021 | -$34.17M(-130.3%) | -$9.50M(-9.0%) | -$34.17M(-16.6%) |
| Sep 2021 | - | -$8.71M(+11.5%) | -$29.32M(-42.3%) |
| Jun 2021 | - | -$9.85M(-60.9%) | -$20.60M(-38.0%) |
| Mar 2021 | - | -$6.12M(-31.9%) | -$14.93M(-29.2%) |
| Dec 2020 | -$14.84M(-58.7%) | -$4.64M(-11.1%) | -$11.56M(-67.0%) |
| Jun 2020 | - | -$4.17M(-51.9%) | -$6.92M(-151.9%) |
| Mar 2020 | - | -$2.75M | -$2.75M |
| Dec 2019 | -$9.35M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Edgewise Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of EWTX is -$110.34M
What is the all-time high annual free cash flow for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual free cash flow is -$9.35M
What is Edgewise Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, EWTX annual free cash flow has changed by -$12.65M (-12.95%)
What is Edgewise Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of EWTX is -$32.63M
What is the all-time high quarterly free cash flow for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly free cash flow is -$2.75M
What is Edgewise Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, EWTX quarterly free cash flow has changed by -$6.31M (-23.98%)
What is Edgewise Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of EWTX is -$125.67M
What is the all-time high TTM free cash flow for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM free cash flow is -$2.75M
What is Edgewise Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, EWTX TTM free cash flow has changed by -$20.95M (-20.00%)